T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Broadcom
AVGO
|
+$2.74B |
| 3 |
Microsoft
MSFT
|
+$2.33B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.47B |
| 5 |
GE Aerospace
GE
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.42B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.44B |
| 3 |
Apple
AAPL
|
+$2.42B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.3B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.73% |
| 2 | Financials | 12.11% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVRI
1876
DELISTED
Everi Holdings
EVRI
| $1.23M | ﹤0.01% |
86,017
+6,053
| +8% | +$84.6K |
|
1877
Crescent Energy
CRGY
$4.03B
| $1.22M | ﹤0.01% |
142,068
+22,400
| +19% | +$196K |
|
1878
Myers Industries
MYE
$1.24B
| $1.22M | ﹤0.01% |
84,331
+5,105
| +6% | +$62.2K |
|
1879
Annexon
ANNX
$867M
| $1.22M | ﹤0.01% |
508,103
-16,638
| -3% | -$33.4K |
|
1880
Univest Financial
UVSP
$1.19B
| $1.22M | ﹤0.01% |
40,632
+899
| +2% | +$26.2K |
|
|
HI
1881
DELISTED
Hillenbrand
HI
| $1.22M | ﹤0.01% |
60,749
+8,211
| +16% | +$171K |
|
1882
Middlesex Water
MSEX
$1.11B
| $1.22M | ﹤0.01% |
22,510
+969
| +4% | +$57.4K |
|
|
PMT
1883
PennyMac Mortgage Investment
PMT
$824M
| $1.21M | ﹤0.01% |
93,940
+4,716
| +5% | +$60.1K |
|
1884
Spectrum Brands
SPB
$2.07B
| $1.21M | ﹤0.01% |
22,780
+3,510
| +18% | +$209K |
|
|
VRNT
1885
DELISTED
Verint Systems
VRNT
| $1.2M | ﹤0.01% |
60,892
+6,675
| +12% | +$117K |
|
|
CIM
1886
Chimera Investment
CIM
$988M
| $1.19M | ﹤0.01% |
86,015
+3,601
| +4% | +$46K |
|
|
EFC
1887
Ellington Financial
EFC
$1.76B
| $1.19M | ﹤0.01% |
91,864
+7,296
| +9% | +$92.8K |
|
1888
Digi International
DGII
$3.23B
| $1.19M | ﹤0.01% |
34,178
+2,312
| +7% | +$70.7K |
|
1889
Evolent Health
EVH
$529M
| $1.19M | ﹤0.01% |
105,762
+7,156
| +7% | +$65.7K |
|
1890
Xenon Pharmaceuticals
XENE
$6.03B
| $1.19M | ﹤0.01% |
+37,935
| New | +$1.24M |
|
1891
Rapid7
RPD
$876M
| $1.19M | ﹤0.01% |
51,336
+5,959
| +13% | +$141K |
|
|
XHR
1892
Xenia Hotels & Resorts
XHR
$1.77B
| $1.18M | ﹤0.01% |
94,186
+2,902
| +3% | +$33.2K |
|
1893
Center Bancorp
CNOB
$1.79B
| $1.18M | ﹤0.01% |
50,926
+7,769
| +18% | +$177K |
|
1894
Arcutis Biotherapeutics
ARQT
$3.29B
| $1.18M | ﹤0.01% |
84,047
+6,107
| +8% | +$85.6K |
|
1895
Pennant Group
PNTG
$1.37B
| $1.18M | ﹤0.01% |
39,441
-472
| -1% | -$12.9K |
|
1896
Sonos
SONO
$1.93B
| $1.18M | ﹤0.01% |
108,888
+7,385
| +7% | +$71.8K |
|
1897
Andersons Inc
ANDE
$2.24B
| $1.18M | ﹤0.01% |
32,017
-12,093
| -27% | -$443K |
|
1898
Cannae Holdings
CNNE
$635M
| $1.18M | ﹤0.01% |
56,414
+3,531
| +7% | +$65.2K |
|
1899
Orchestra BioMed
OBIO
$265M
| $1.18M | ﹤0.01% |
438,369
-21,751
| -5% | -$63.5K |
|
1900
Sable Offshore Corp
SOC
$796M
| $1.18M | ﹤0.01% |
53,449
+11,651
| +28% | +$271K |
|
Similar funds
T. Rowe Price Associates's Q2 2025 Portfolio in Review
As of Q2 2025, T. Rowe Price Associates held 3,193 positions worth $883B, up 8.8% from $812B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2025 filing shows 153 new, 2,010 increased, 803 reduced and 136 closed positions. Its largest new stake was Ralliant Corp: 4,667,638 shares worth $226M. The largest sale was Amazon, an estimated $3.42B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q2 2025 buy was Ralliant Corp: 4,667,638 shares worth $226M.
- T. Rowe Price Associates added most to NVIDIA in Q2 2025, an estimated $3.94B increase.
- T. Rowe Price Associates's biggest Q2 2025 reduction was Amazon, cutting an estimated $3.42B.
- T. Rowe Price Associates fully exited US Steel in Q2 2025, selling an estimated $146M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $883B portfolio in Q2 2025.
- T. Rowe Price Associates opened 153 new positions and closed 136 in Q2 2025.
- T. Rowe Price Associates's portfolio value rose 8.8% quarter-over-quarter to $883B.
Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.